BALVERSA
BALVERSA
Approved
DIN Number
02493233
Drug Class
Human
Market Date
Dec 9, 2019
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02493233
AIG Number0161931003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EN01 ERDAFITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ERDAFITINIBActive
Strength: 5 MG
Monograph: ERDAFITINIB